25
Participants
Start Date
May 18, 2015
Primary Completion Date
December 17, 2024
Study Completion Date
December 17, 2024
Nusinersen
Solution for intrathecal injection
National Taiwan University Hospital, Taipei
Ospedale Pediatrico Bambino Gesù, Rome
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Hamad General Hospital, Doha
Royal Children's Hospital, Parkville
Queensland Children's Hospital, South Brisbane
Hacettepe University Medical Faculty, Ankara
Columbia University, New York
The Children's Hospital of Philadelphia, Philadelphia
Fondazione Serena Onlus - Centro Clinico Nemo, Milan
The Johns Hopkins Hospital, Baltimore
Yeditepe University Medical School Hospital, Istanbul
Nemours Children's Hospital, Orlando, Orlando
Universitaetsklinikum Freiburg, Freiburg im Breisgau
Children's Hospital Colorado, Aurora
University of Utah, Salt Lake City
David Geffen School of Medicine, Los Angeles
University of California Davis Health System, Sacramento
Seattle Children's Research Institute, Seattle
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Massachusetts General Hospital, Boston
Lead Sponsor
Biogen
INDUSTRY